We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
138 hedge funds and large institutions have $313M invested in ANI Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 48 increasing their positions, 34 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
143% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 14
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
62% more capital invested
Capital invested by funds: $194M → $313M (+$120M)
41% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 34
14% more funds holding
Funds holding: 121 → 138 (+17)
5% more call options, than puts
Call options by funds: $12M | Put options by funds: $11.5M
Holders
138
Holders Change
+17
Holders Change %
+14.05%
% of All Funds
3.68%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
34
Increased
48
Reduced
34
Closed
14
Calls
$12M
Puts
$11.5M
Net Calls
+$519K
Net Calls Change
+$3.13M
Top Buyers
| 1 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$9.23M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$8.7M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$6.64M |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.45M |
| 5 |
Renaissance Technologies
New York
|
+$3.59M |
